# University of Tsukuba Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-tsukuba-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 27 |
| Citations | 111,551 |
| City | Tsukuba |
| Country | JP |
| Description | University of Tsukuba Hospital is a research organisation in Tsukuba, JP. OpenAlex records 4,031 works and 111,551 citations for it. 1,038 researchers list it as their most recent affiliation. |
| Homepage | http://www.s.hosp.tsukuba.ac.jp/english |
| OpenAlex ID | https://openalex.org/I4210114927 |
| Researchers | 1,038 |
| ROR ID | https://ror.org/028fz3b89 |
| Type | healthcare |
| Works | 4,031 |

## University papers

- [Frequent pathway mutations of splicing machinery in myelodysplasia](https://scholariq.org/papers/frequent-pathway-mutations-of-splicing-machinery-in-myelodysplasia/)
- [Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms](https://scholariq.org/papers/recurrent-mutations-in-multiple-components-of-the-cohesin-complex-in-myeloid/)
- [Repression via the GATA box is essential for tissue-specific erythropoietin gene expression](https://scholariq.org/papers/repression-via-the-gata-box-is-essential-for-tissue-specific-erythropoietin-gene/)
- [Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic β-Type Globin Promoters in Differentiated Adult Erythroid Cells](https://scholariq.org/papers/nuclear-receptors-tr2-and-tr4-recruit-multiple-epigenetic-transcriptional/)
- [Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels](https://scholariq.org/papers/identification-and-characterization-of-2-types-of-erythroid-progenitors-that/)
- [Interleukin-6 and Tumor Necrosis Factor-α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome](https://scholariq.org/papers/interleukin-6-and-tumor-necrosis-factor-in-patients-with-obstructive-sleep-apnea/)
- [Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice](https://scholariq.org/papers/reduced-tet2-function-leads-to-t-cell-lymphoma-with-follicular-helper-t-cell/)
- [Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial](https://scholariq.org/papers/addition-of-danicopan-to-ravulizumab-or-eculizumab-in-patients-with-paroxysmal/)
- [Clinical significance of disease‐specific <i><scp>MYD</scp>88</i> mutations in circulating <scp>DNA</scp> in primary central nervous system lymphoma](https://scholariq.org/papers/clinical-significance-of-disease-specific-i-scp-myd-scp-88-i-mutations-in/)
- [Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease](https://scholariq.org/papers/oral-administration-of-k-11706-inhibits-gata-binding-activity-enhances-hypoxia/)
- [Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria](https://scholariq.org/papers/hemolysis-induced-by-sars-cov-2-mrna-vaccination-in-patients-with-paroxysmal/)

## University researchers

- [Naoshi Obara](https://scholariq.org/researchers/naoshi-obara/)

## University top topics

Showing 8 of 25.

- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Radiation Therapy and Dosimetry](https://scholariq.org/topics/radiation-therapy-and-dosimetry/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
